261 related articles for article (PubMed ID: 31014974)
1. 2,3,7,8-Tetrachloodibenzo-p-dioxin affects the differentiation of CD4 helper T cell.
Pang C; Zhu C; Zhang Y; Ge Y; Li S; Huo S; Xu T; Stauber RH; Zhao B
Toxicol Lett; 2019 Sep; 311():49-57. PubMed ID: 31014974
[TBL] [Abstract][Full Text] [Related]
2. Developmental exposure to 2,3,7,8 tetrachlorodibenzo-p-dioxin attenuates capacity of hematopoietic stem cells to undergo lymphocyte differentiation.
Ahrenhoerster LS; Tate ER; Lakatos PA; Wang X; Laiosa MD
Toxicol Appl Pharmacol; 2014 Jun; 277(2):172-82. PubMed ID: 24709672
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization and gene expression analysis of CD4+ CD25+ regulatory T cells generated in mice treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Marshall NB; Vorachek WR; Steppan LB; Mourich DV; Kerkvliet NI
J Immunol; 2008 Aug; 181(4):2382-91. PubMed ID: 18684927
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric analysis of lymphocyte subpopulations in the spleen and thymus of mice exposed to an acute immunosuppressive dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
Kerkvliet NI; Brauner JA
Environ Res; 1990 Aug; 52(2):146-54. PubMed ID: 2118453
[TBL] [Abstract][Full Text] [Related]
5. An enhanced postnatal autoimmune profile in 24 week-old C57BL/6 mice developmentally exposed to TCDD.
Mustafa A; Holladay SD; Goff M; Witonsky SG; Kerr R; Reilly CM; Sponenberg DP; Gogal RM
Toxicol Appl Pharmacol; 2008 Oct; 232(1):51-9. PubMed ID: 18534654
[TBL] [Abstract][Full Text] [Related]
6. T lymphocytes are direct, aryl hydrocarbon receptor (AhR)-dependent targets of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): AhR expression in both CD4+ and CD8+ T cells is necessary for full suppression of a cytotoxic T lymphocyte response by TCDD.
Kerkvliet NI; Shepherd DM; Baecher-Steppan L
Toxicol Appl Pharmacol; 2002 Dec; 185(2):146-52. PubMed ID: 12490139
[TBL] [Abstract][Full Text] [Related]
7. Targeted deletion of the aryl hydrocarbon receptor in dendritic cells prevents thymic atrophy in response to dioxin.
Beamer CA; Kreitinger JM; Cole SL; Shepherd DM
Arch Toxicol; 2019 Feb; 93(2):355-368. PubMed ID: 30499018
[TBL] [Abstract][Full Text] [Related]
8. The immunotoxic effects of dual exposure to PCP and TCDD.
Chen HM; Lee YH; Chen RJ; Chiu HW; Wang BJ; Wang YJ
Chem Biol Interact; 2013 Nov; 206(2):166-74. PubMed ID: 24051191
[TBL] [Abstract][Full Text] [Related]
9. AhR Ligands Differentially Regulate miRNA-132 Which Targets HMGB1 and to Control the Differentiation of Tregs and Th-17 Cells During Delayed-Type Hypersensitivity Response.
Abdulla OA; Neamah W; Sultan M; Chatterjee S; Singh N; Nagarkatti M; Nagarkatti P
Front Immunol; 2021; 12():635903. PubMed ID: 33679792
[TBL] [Abstract][Full Text] [Related]
10. Differential relative effect potencies of some dioxin-like compounds in human peripheral blood lymphocytes and murine splenic cells.
van Ede KI; Gaisch KP; van den Berg M; van Duursen MB
Toxicol Lett; 2014 Apr; 226(1):43-52. PubMed ID: 24472611
[TBL] [Abstract][Full Text] [Related]
11. 2,3,7,8-Tetrachlorodibenzo-p-dioxin prompted differentiation to CD4
Cho MK; Park JG; Iwata H; Kim EY
Ecotoxicol Environ Saf; 2021 Mar; 211():111947. PubMed ID: 33503546
[TBL] [Abstract][Full Text] [Related]
12. 2,3,7,8-Tetrachlorodibenzo-p-dioxin modulates functional differentiation of mouse bone marrow-derived dendritic cells Downregulation of RelB by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Lee JA; Hwang JA; Sung HN; Jeon CH; Gill BC; Youn HJ; Park JH
Toxicol Lett; 2007 Aug; 173(1):31-40. PubMed ID: 17681673
[TBL] [Abstract][Full Text] [Related]
13. Early consequences of 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on the activation and survival of antigen-specific T cells.
Funatake CJ; Dearstyne EA; Steppan LB; Shepherd DM; Spanjaard ES; Marshak-Rothstein A; Kerkvliet NI
Toxicol Sci; 2004 Nov; 82(1):129-42. PubMed ID: 15310856
[TBL] [Abstract][Full Text] [Related]
14. 2,3,7,8-tetrachlorodibenzo-p-dioxin causes alterations in lymphocyte development and thymic atrophy in hemopoietic chimeras generated from mice deficient in ARNT2.
Laiosa MD; Lai ZW; Thurmond TS; Fiore NC; DeRossi C; Holdener BC; Gasiewicz TA; Silverstone AE
Toxicol Sci; 2002 Sep; 69(1):117-24. PubMed ID: 12215665
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of TC-1 cytokine production, effector cytotoxic T lymphocyte development and alloantibody production by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Kerkvliet NI; Baecher-Steppan L; Shepherd DM; Oughton JA; Vorderstrasse BA; DeKrey GK
J Immunol; 1996 Sep; 157(6):2310-9. PubMed ID: 8805628
[TBL] [Abstract][Full Text] [Related]
16. Suppression of experimental autoimmune uveoretinitis by inducing differentiation of regulatory T cells via activation of aryl hydrocarbon receptor.
Zhang L; Ma J; Takeuchi M; Usui Y; Hattori T; Okunuki Y; Yamakawa N; Kezuka T; Kuroda M; Goto H
Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):2109-17. PubMed ID: 20007828
[TBL] [Abstract][Full Text] [Related]
17. Role of aryl hydrocarbon receptor (AHR) in overall retinoid metabolism: Response comparisons to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure between wild-type and AHR knockout mice.
Esteban J; Sánchez-Pérez I; Hamscher G; Miettinen HM; Korkalainen M; Viluksela M; Pohjanvirta R; Håkansson H
Reprod Toxicol; 2021 Apr; 101():33-49. PubMed ID: 33607186
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of TCDD-induced suppression of antibody production: effect on T cell-derived cytokine production in the primary immune reaction of mice.
Ito T; Inouye K; Fujimaki H; Tohyama C; Nohara K
Toxicol Sci; 2002 Nov; 70(1):46-54. PubMed ID: 12388834
[TBL] [Abstract][Full Text] [Related]
19. Suppression of human B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin involves altered regulation of B cell lymphoma-6.
Phadnis-Moghe AS; Crawford RB; Kaminski NE
Toxicol Sci; 2015 Mar; 144(1):39-50. PubMed ID: 25543051
[TBL] [Abstract][Full Text] [Related]
20. Cutting edge: activation of the aryl hydrocarbon receptor by 2,3,7,8-tetrachlorodibenzo-p-dioxin generates a population of CD4+ CD25+ cells with characteristics of regulatory T cells.
Funatake CJ; Marshall NB; Steppan LB; Mourich DV; Kerkvliet NI
J Immunol; 2005 Oct; 175(7):4184-8. PubMed ID: 16177056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
